Member Info for Offgrid

A licence deal with upfront cash and regular royalty payments there afte would be my guess.

https://www.***************************/genflow-biosciences-dr-eric-leire-highlights-funding-pipeline-progress-and-near-term-catalysts/4121249777

not sure if anyone has seen this interview with eric from last month, but the answer to the question about future prospects and possible reaction of share price when they sign partnership deals was very positive

This drop in price today is manipulated by the MM's to trigger stop loss trades, but again the sells showing on here are buys, I did another top up at 2.37p this afternoon. Like everyone else including the warrant holders who will get there shares next wednesday, we are waiting for the good news to hopefully start rolling in.

This just seems to be trundling along the bottom at the moment, you can't even trade it as the spread is to wide, I will keep a core position here but i have sold a chunk and moved it to a different biotech i believe has much better propects in the short term. "Genflow bio", its worth a look

Sorry Companies, fat fingers on keyboard😂

This was sitting on the sidelines all day, the MM's were accumulating the weak hand sells this morning to supply this large order. this looks very bullish to me. As you said Porter, one of the Copampanies under CDA trying to get a foothold perhaps.

MM's accumulating, ready for next week, anything above 2.5p is a buy today

Excellent analysis as always Picked Peck, If it plays out as you have suggested, next week should get very interesting

Thanks for the info Picked Peck, I would imagine there will be an RNS before the presentation if Genflow was going to be mentioned as it would be classed as inside information if Hilda Au was going to name check them at the presentation. But would'nt that be something.

A little quiet this morning, although I did buy a few more, could'nt help myself, but I have to say it is showing as a sell on here, so basically everything this morning above 2.8p is a buy.

The running order for the convention that Aquitas are attending next looks interesting, they are presenting 4 presentations and I think it is the one with "Hilda Au" on liver gene expression profiles will be relevant to genflow, or at least i think it will, our resident expect can clarify that for us, but i expect we will get an RNS before next wednesday.

I wonder if the US investors have a whiff of something, RNS tomorrow ? also those 4 large off book trades of 500000 plus shares this afternoon were probably MM negotiated buys, someone wanted 2million shares

I managed to buy a final block this morning, but the buys are really rolling in know, more positive news around the corner and the 2's will be a distant memory, the mm's must be running low on shares , they will have too close the spread right up

Thats useful information to know Moneymunch, I had'nt realised myself that Genflow were on the main market, you always assume small cap Biotech must be AIM. That in itself shows confidence from the Directors when they listed on the main market as there is much more oversight and transparency than the wildwest AIM and again makes this more attractive to US investors.

I have been invested here for quite some time and adding more on the dips, the news flow recently is just dropping into place nicely, I also had a small position in another Biotech called Immupharma, but sold out my position in January as things did'nt seem to add up there, lots of its just around the corner and we need another raise.

I would imagine the Tier 1 Players have already had a peek at the raw data from UCLA before the official release and they are being kept in the loop with constant updates. I would just like to see this finish above 3p before the long weekend

Could the results be released late morning, Gad is based in New York so it would tie in with the American pre market, just a thought

Until we get some sort of resolution and oil coming down, this will just drift, hopefully not down too much more.

Although I did trim a few the other day, moved it into a small Biotech called Genflow. Big things just around the corner, do some research, IMHO

2.9p being paid, 3p at the close maybe

I sold out here a few weeks ago as it seemed to be draging on too long, if anyone is interested have a look at Genflow, much better prospect than here. IMHO

I suppose we can all speculate as to where this might end up, but I am sure this week could be the start of a rerate and a push above 5p in the short term

I have done a bit of digging and i'm not going into the science , we have a resident expert with PP, but with the help of the AI does this sound feasable, I hope it does.

The "Nasdaq" Inference

Berdugo’s recent timeline isn't that of a "maintenance" Chairman. It’s the timeline of an Architect.

Step 1: Fix the science (focus on SIRT6/LNP).

Step 2: Secure the delivery (Acuitas).

Step 3: Protect the IP (April 13 Patent).

Step 4: Introduce the story to US investors (Bloom Burton).

Step 5 (Next): Use the UCLA data to justify a high-value US listing.

The Verdict: Gad Berdugo is effectively the "General" leading the charge across the Atlantic. If the results this week hint at a US listing, it confirms that his meetings in New York and Toronto have been successful.